VERSANT HCV Genotype 2.0 Assay (LiPA)

VERSANT HCV Genotype 2.0 Assay (LiPA)

Highly Accurate HCV Genotype and Subtype Detection

The VERSANT® HCV Genotype 2.0 Assay (LiPA)* utilizes the trusted reverse-hybridization technology to detect genotypes 1-6 and subtypes 1a and 1b. This assay is used with the Auto-LiPA 48 and AutoBlot 3000H automated systems to provide highly accurate identification of HCV genotypes and subtypes for optimal patient therapy.

  • Proven Reliability
  • Total Genotyping Solution
Contact Us

Features & Benefits

The VERSANT HCV Genotype 2.0 Assay (LiPA)* uses the trusted reverse-hybridization technology to provide accurate identification of HCV genotype and subtype specific data for optimal patient therapy.

  • Highly accurate differentiation of subtypes 1a vs.1b showing more than 98% concordance with NS5B sequencing
  • Increased genotyping and subtyping accuracy due to dual target analysis of 5’ non coding and core viral genomic regions 
  • Most widely used HCV genotyping assay
  • Trusted reverse-hybridization technology (LiPA)
  • Validated with NS5B sequencing
  • Full integration from extraction to automated interpretation
  • Minimal hands-on time as most manual steps are automated with the Auto-LiPA 48 or AutoBlot 3000H systems

“The determination of hepatitis C virus (HCV) genotype is mandatory to tailor peginterferon-ribavirin treatment dose and duration. Subtype determination is likely to become useful to tailor specific HCV inhibitor therapy and interpret resistance profiles in the near future. The new VERSANT Genotype Assay (LiPA), a second generation line probe assay, contains probes targeting both the 5’ non coding and the core regions of the viral genome. This has improved the accuracy of HCV genotype 1 subtype determination, particularly discrimination between subtypes 1a and 1b, the most frequent HCV subtypes in clinical practice. The assay also displays improved discrimination among HCV genotypes 1 and 6 relative to the previous version. Only 4% of clinical specimens are mistyped with the VERSANT Genotype Assay relative to the reference method (direct sequence analysis of the NS5B region), which makes it the most accurate method for use in clinical practice. The assay is user-friendly and provides quick results.”

Stèphane Chevaliez
Assistant Hospitalier Universitaire
Centre National de Référence des Hépatites B, C et delta
Laboratoire de Virologie et Inserm U841
Hospital Henri Mondor
Universite Paris XII
94010 CRETEIL, FRANCE

Technical Details

Ordering Information

Systems

Catalog No.

Product

No. of Tests

10313066

Auto-LiPA 48 Genotyping Instrument

48 Tests/Run

10315618

AutoBlot 3000H Genotyping Instrument

20 Tests/Run

10282928

VERSANT kPCR Sample Prep

1 Unit

10702391

VERSANT kPCR SP Workstation Kit

1 Unit

Reagents

10492004

VERSANT HCV Genotype 2.0 Assay

40 Tests

10492005

VERSANT HCV Genotype 2.0 Assay

100 Tests

10719666

VERSANT HCV Amplification 2.0 Kit

40 Tests

10719667

VERSANT HCV Amplification 2.0 Kit

100 Tests

10719668

VERSANT HCV Control 2.0 Kit

6 Tests

Software and Scanner

10492006

LiPA - Scan HCV IVD Software V1.00

1 Unit

10817497

LiPA SP 2.0 Software Installation Kit

1 Unit

10322207

Scanner, LiPA-Scan-verified (110 V)

1 Unit

LiPA Consumables

10325628
Auto-LiPA 48 Strips Tray (25 per set)
10315381
AutoBlot 3000 Strips Tray (25 per set)
10329226
VERSANT LiPA Scan Reading Template (25 templates)